Heparin and heparan sulfate: structure and function
The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Abstract
This review covers the structure and function of heparin and heparan sulfate glycosaminoglycans. Their chemical structures are discussed, including recently developed methods for sequencing picomole to nanomole quantities of heparin- and heparan sulfate-derived oligosaccharides. The biosynthesis of heparin and heparan sulfate is reviewed as it relates to their diverse and varied structures, and their biological activities and functions are discussed. The literature up to August 2001 is reviewed, and 208 references are cited.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Cobalt(II)-Nitronyl Nitroxide Chains as Molecular Magnetic Nanowires
Caneschi, A., Gatteschi, D., Lalioti, N., Sangregorio, C., Sessoli, R., Venturi, G., Vindigni, A., Rettori, A., Pini, M. G., & Novak, M. A. (2001) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20010504)40:9<1670::aid-anie16700>3.3.co;2-h · Cited by 1,154
A Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry
Shukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, X., Esko, J. D., Cohen, G. H., Eisenberg, R. J., Rosenberg, R. D., & Spear, P. G. (1999) · Cell · doi:10.1016/s0092-8674(00)80058-6 · Cited by 1,054
Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis
Goldberg, I. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37569-6 · Cited by 1,010
Molecular diversity of heparan sulfate
Esko, J. D., & Lindahl, U. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13530 · Cited by 951
Formation of anhydrosugars in the chemical depolymerization of heparin
Shively, J. E., & Conrad, H. E. (1976) · Biochemistry · doi:10.1021/bi00663a005 · Cited by 901
Heparin Structure and Interactions with Basic Fibroblast Growth Factor
Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J., & Rees, D. C. (1996) · Science · doi:10.1126/science.271.5252.1116 · Cited by 798
Growth factors in the extracellular matrix.
Taipale, J., & Keski‐Oja, J. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.1.9034166 · Cited by 759
Specificities of heparan sulphate proteoglycans in developmental processes
Perrimon, N., & Bernfield, M. (2000) · Nature · doi:10.1038/35008000 · Cited by 714
Regulated Diversity of Heparan Sulfate
Lindahl, U., Kusche-Gullberg, M., & Kjellén, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.24979 · Cited by 678
Counterion binding in polyelectrolyte theory
Manning, G. S. (1979) · Accounts of Chemical Research · doi:10.1021/ar50144a004 · Cited by 627
Cited by
Items 201–300 of 907
Synthesis of heparin oligosaccharides and their interaction with eosinophil-derived neurotoxin.
Hung, S.-C., Lu, X.-A., Lee, J.-C., Chang, M., Fang, S.-L., Fan, T., Zulueta, M. M., & Zhong, Y. (2012) · Organic and biomolecular chemistry · doi:10.1039/c1ob06415k · Cited by 44
Langeslay, D. J., Young, R. P., Béni, S., Beecher, C. N., Mueller, L. J., & Larive, C. K. (2012) · Glycobiology · doi:10.1093/glycob/cws085 · Cited by 43
Shang, F., Gao, N., Yin, R., Lin, L., Xiao, C., Zhou, L., Li, Z., Purcell, S. W., Wu, M., & Zhao, J. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.047 · Cited by 50
A scar-like lesion is apparent in basement membrane after wound repair in vivo
Ramos-Lewis, W., LaFever, K. S., & Page, A. W. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.07.004 · Cited by 50
“The heparan sulfate chains that characterize heparan sulfate proteoglycans like perlecan can interact with hundreds of different proteins [42].”
BackgroundA non-anticoagulant heparin-like snail glycosaminoglycan promotes healing of diabetic wound
Wu, Y., Zhou, Z., Luo, L., Tao, M., Chang, X., Yang, L., Huang, X., Hu, L., & Wu, M. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116682 · Cited by 51
Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy
Berdiaki, A., Neagu, M. T., Giatagana, E.-M., Николаевич, К. А., Tsatsakis, A. M., Tzanakakis, G. N., & Nikitovic, D. (2021) · Biomolecules · doi:10.3390/biom11030395 · Cited by 52
“Hep is synthesized only in connective tissue-type mast cells or basophils [49].”
BackgroundLiu, Z., Wang, Y.-T., & Zhang, N. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.689284 · Cited by 51
“Heparin has the highest negative charge density of any known biological molecule [44,45].”
BackgroundMcAllister, N., Liu, Y., Silva, L. M., Lentscher, A. J., Chai, W., Wu, N., Griswold, K. A., Raghunathan, K., Vang, L., Alexander, J., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01500-20 · Cited by 53
“Although heparin and HS are structurally similar, heparin is a more highly sulfated version of HS, composed of more iduronic acid, and is often used experimentally instead of HS due to accessibility and cost (54, 59).”
BackgroundHu, J., Liu, B. R., Wu, C.-Y., Lu, S.-W., & Lee, H. (2009) · Peptides · doi:10.1016/j.peptides.2009.06.006 · Cited by 49
Heparan Sulfate Degradation via Reductive Homolysis of Its N-Chloro Derivatives
Rees, M. D., & Davies, M. J. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0577239 · Cited by 49
Chan, C. W., & Smith, D. K. (2016) · Chemical Communications · doi:10.1039/c6cc00163g · Cited by 49
Zeng, K., Groth, T., & Zhang, K. (2018) · ChemBioChem · doi:10.1002/cbic.201800569 · Cited by 54
Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo
de Boer, C., Armstrong, Z., Lit, V. A. J., Barash, U., Ruijgrok, G., Boyango, I., Weitzenberg, M. M., Schröder, S. P., Sarris, A. J. C., Meeuwenoord, N. J., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2203167119 · Cited by 51
The structural basis of PTEN regulation by multi-site phosphorylation
Dempsey, D. R., Viennet, T., Iwase, R., Park, E., Henriquez, S., Chen, Z., Jeliazkov, J. R., Palanski, B. A., Phan, K. L., Coote, P. W., et al. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00668-5 · Cited by 48
Mehta, P., Lee, H., & Lee, K.-H. (2017) · Biosensors & bioelectronics · doi:10.1016/j.bios.2017.01.002 · Cited by 46
Wu, F., Xu, T., Zhao, G.-Y., Meng, S., Wan, M.-M., Chi, B., Mao, C., & Shen, J. (2017) · Langmuir · doi:10.1021/acs.langmuir.7b00567 · Cited by 43
Osteoactivin Promotes Osteoblast Adhesion Through HSPG and αvβ1 Integrin
Moussa, F. M., Arango, I., Sondag, G. R., Scott, E. M., Frara, N. A., Abdelmagid, S. M., & Safadi, F. F. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24760 · Cited by 56
Park, H., Kim, M., Kim, H., Lee, Y., Seo, Y., Pham, D., Lee, J., Byun, S. J., & Kwon, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-14793-z · Cited by 51
Trim, P. J., Hopwood, J. J., & Snel, M. F. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b01743 · Cited by 47
Rudd, T. R., Preston, M. D., & Yates, E. A. (2017) · Molecular BioSystems · doi:10.1039/c6mb00857g · Cited by 49
Heparin and Its Derivatives: Challenges and Advances in Therapeutic Biomolecules
Banik, N., Yang, S.-B., Kang, T., Lim, J.-H., & Park, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910524 · Cited by 37
“Considering the disadvantages of the direct use of natural GAG, GAG-mimetic biomolecules have become the key of biofunctions these days [1].”
BackgroundInfluentialMarine Non-Glycosaminoglycan Sulfated Glycans as Potential Pharmaceuticals
Pomin, V. H. (2015) · Pharmaceuticals · doi:10.3390/ph8040848 · Cited by 52
“For instance, while heparin is largely N-sulfated, O-sulfated frequently at positions C6 and rarely at C3 of the composing GlcN units with additional sulfation at the C2 position of the IdoA units [27–29], chondroitin sulfate bears sulfation mostly at positions C4 and/or C6 of its N-acetyl GalN (GalNAc) units (Figure…”
BackgroundLiu, J., Zhou, L., He, Z., Gao, N., Shang, F., Xu, J., Li, Z., Yang, Z., Wu, M., & Zhao, J. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.10.091 · Cited by 48
Abune, L., Zhao, N., Lai, J., Peterson, B. E., Szczesny, S. E., & Wang, Y. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00423 · Cited by 46
Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells
Fadnes, B., Uhlin‐Hansen, L., Lindin, I., & Rekdal, Ø. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-116 · Cited by 47
“The negatively charged glycosaminoglycans (GAGs) attached to the core protein of cell surface proteoglycans consist of repeating disaccharides and are highly sulfated [25,26].”
BackgroundDabo, S. M., Confer, A. W., ANDERSON, B. E., & Gupta, S. (2006) · Infection and Immunity · doi:10.1128/iai.74.5.2513-2521.2006 · Cited by 51
“The binding sites and/or mode of interactions of Hep with the Hep-1 and Hep-2 domains of Fn have been reported for several pathogens and adhesins (29, 38).”
BackgroundChen, Y., Leask, A., Abraham, D., Pala, D., Shiwen, X., Khan, K., Liu, S., Carter, D. E., Wilcox‐Adelman, S. A., Goetinck, P. F., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23146 · Cited by 49
Not Just Anticoagulation—New and Old Applications of Heparin
Zang, L., Zhu, H., Wang, K., Liu, Y., Yu, F., & Zhao, W. G. (2022) · Molecules · doi:10.3390/molecules27206968 · Cited by 50
“ronic acid, and O-sulfation at different sites of the chain [13,14].”
BackgroundHuang, R., Liu, J., & Sharp, J. (2013) · Analytical Chemistry · doi:10.1021/ac400439a · Cited by 44
Bromfield, S. M., Posocco, P., Chan, C. W., Calderón, M., Guimond, S. E., Turnbull, J. E., Pricl, S., & Smith, D. K. (2014) · Chemical Science · doi:10.1039/c4sc00298a · Cited by 45
Synthesis, characterization and anticoagulant activity of chitosan derivatives
Imran, M., Sajwan, M., Alsuwayt, B., & Asif, M. (2019) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2019.11.003 · Cited by 47
“The synthesized chitosan derivatives are supposed to bear similar anticoagulant mechanism of action like heparin and fondaparinux due to similarity in their structures (Rabenstein, 2002; Weitz & Weitz, 2010).”
Skidmore, M. A., Guimond, S. E., Rudd, T. R., Fernig, D. G., Turnbull, J. E., & Yates, E. A. (2008) · Connective Tissue Research · doi:10.1080/03008200802148595 · Cited by 45
“The glucosamine residue also can be N-acetylated (GlcNAc) and N-sulfated (GlcNS) and has been reported as the free amine (GlcN) [9].”
BackgroundZhang, C., Liu, Y., Gao, Y., Shen, J., Zheng, S., Wei, M., & Zeng, X. (2009) · International Journal of Cancer · doi:10.1002/ijc.24561 · Cited by 50
“with proteins, which, in many cases, involve the interaction between cationic side chains of the protein and anionifc sites on heparin.(14) The modified heparins still remain the high negative charge although they have been modified in structure, and it is well known that integrin molecule contains several (6 or 7) di…”
BackgroundSynthetic heparin and heparan sulfate oligosaccharides and their protein interactions
Zulueta, M. M. L., Lin, S., Hu, Y., & Hung, S. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.10.008 · Cited by 44
“It is, however, more homogeneous with N-sulfonated and 6-O-sulfonated GlcN (GlcNS6S) and 2-O-sulfonated IdoA (IdoA2S) occupying most of the chain [9].”
BackgroundDesign and Synthesis of Unnatural Heparosan and Chondroitin Building Blocks
Bera, S., & Linhardt, R. J. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo200076z · Cited by 47
Production methods for heparosan, a precursor of heparin and heparan sulfate
Chavaroche, A. A. E., van den Broek, L. A. M., & Eggink, G. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.04.046 · Cited by 44
Functional Augmentation of Naturally-Derived Materials for Tissue Regeneration
Allen, A. B., Priddy, L. B., Li, M.-T. A., & Guldberg, R. E. (2014) · Annals of Biomedical Engineering · doi:10.1007/s10439-014-1192-4 · Cited by 45
Fluorous-Tag Assisted Syntheses of Sulfated Keratan Sulfate Oligosaccharide Fragments
Bhaduri, S., & Pohl, N. L. B. (2016) · Organic Letters · doi:10.1021/acs.orglett.6b00344 · Cited by 46
A ratiometric scheme for the fluorescent detection of protamine, a heparin antidote
Pandey, S. P., & Singh, P. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.112589 · Cited by 31
Abzalimov, R. R., Dubin, P. L., & Kaltashov, I. A. (2007) · Analytical Chemistry · doi:10.1021/ac0710432 · Cited by 44
Zhang, Y., Man, J., Liu, J., Li, J., Song, X., Wang, J., Li, J., & Chen, Y. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c05077 · Cited by 43
Zhu, K., Zhang, Z., Li, G., Sun, J., Gu, T., Ain, N. U., Zhang, X., & Li, D. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128878 · Cited by 49
Recent advances in the design and immobilization of heparin for biomedical application: A review
Gupta, S., Puttaiahgowda, Y. M., & Deiglmayr, L. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130743 · Cited by 44
Chertok, B., Langer, R., & Anderson, D. G. (2016) · ACS Nano · doi:10.1021/acsnano.6b01199 · Cited by 44
Analyses of Interactions Between Heparin and the Apical Surface Proteins of Plasmodium falciparum
Kobayashi, K., Takano, R., Takemae, H., Sugi, T., Ishiwa, A., Gong, H., Recuenco, F. C., Iwanaga, T., Horimoto, T., Akashi, H., et al. (2013) · Scientific Reports · doi:10.1038/srep03178 · Cited by 43
Characterization of currently marketed heparin products: key tests for quality assurance
Keire, D. A., Ye, H., Trehy, M. L., Ye, W., Kolinski, R. E., Westenberger, B. J., Buhse, L. F., Nasr, M. M., & Al-Hakim, A. H. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-4023-y · Cited by 43
“Heparin is a complex mixture of sulfated glycosaminoglycans (GAGs) [1, 2], and tons of this polyanionic polymer are used every year as an anticoagulant or anti-thrombotic agent [3, 4].”
BackgroundAyres, N., Holt, D. J., Jones, C. F., Corum, L. E., & Grainger, D. W. (2008) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.23075 · Cited by 49
Zhu, C., Yang, Q., Liu, L., & Wang, S. (2011) · Journal of Materials Chemistry · doi:10.1039/c0jm04424e · Cited by 43
A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential
Brito, A. S., Cavalcante, R. S., Palhares, L. C. G. F., Hughes, A. J., Andrade, G. P. V., Yates, E. A., Nader, H. B., de Lima, M. A., & Chavante, S. F. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2013.08.063 · Cited by 46
“The and, more rarely, G residues can be O-sulfated at position C-2 I2S and G2S, respectively) whereas A residues can be N-sulfated ANS), N-acetylated (ANAC) and frequently 6-O-sulfated (A6S) (Bisio t al., 2009; Guerrini et al., 2013; Rabenstein, 2002).”
BackgroundGuerrini, M., Rudd, T. R., Mauri, L., Macchi, E., Fareed, J., Yates, E. A., Naggi, A., & Torri, G. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b01366 · Cited by 42
McLendon, P. M., Buckwalter, D. J., Davis, E. M., & Reineke, T. M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100135n · Cited by 49
Xu, B., Wu, X.-F., Li, H., Tong, H., & Wang, L.-X. (2012) · Polymer · doi:10.1016/j.polymer.2011.11.058 · Cited by 39
Interaction of Antithrombin with Sulfated, Low Molecular Weight Lignins
Henry, B., Connell, J. G., Liang, A.-Y., Krishnasamy, C., & Desai, U. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.013359 · Cited by 43
A simple new competition assay for heparin binding in serum applied to multivalent PAMAM dendrimers
Bromfield, S. M., Posocco, P., Fermeglia, M., Pricl, S., Rodríguez‐López, J., & Smith, D. K. (2013) · Chemical Communications · doi:10.1039/c3cc41251b · Cited by 42
Cultivation conditions affect the monosaccharide composition in Ulva fenestrata
Olsson, J., Toth, G. B., Oerbekke, A., Cvijetinovic, S., Wahlström, N., Harrysson, H., Steinhagen, S., Kinnby, A., White, J. C. B., Edlund, U., et al. (2020) · Journal of Applied Phycology · doi:10.1007/s10811-020-02138-9 · Cited by 43
“…known to be an important factor for the biological function of the anticoagulant heparin (Esko and Selleck 2002), which shares some structural elements with ulvan as it is also composed of disaccharides of sulfated neutral sugars with glucuronic or iduronic acid moieties attached (Rabenstein 2002).”
BackgroundGlycosaminoglycan‐Induced Emissive J‐Aggregate Formation in a meso‐Ester BODIPY Dye
Kim, D., Lee, U., Bouffard, J., & Kim, Y. (2020) · Advanced Optical Materials · doi:10.1002/adom.201902161 · Cited by 44
Keire, D. A., Mans, D. J., Ye, H., Kolinski, R. E., & Buhse, L. F. (2010) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2010.02.019 · Cited by 42
Patel, R. P., Narkowicz, C., & Jacobson, G. A. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.01.007 · Cited by 42
dos Santos, G. R. C., Tovar, A. M. F., Capillé, N. V., Pereira, M. S., Pomin, V. H., & Mourão, P. A. S. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.07.004 · Cited by 42
Nguyen, K., & Rabenstein, D. L. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b12235 · Cited by 40
Self-citationMalagoli, B. G., Cardozo, F. T. G. S., Gomes, J. H. D. S., Ferraz, V. P., Simões, C. M. O., & Braga, F. C. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.02.053 · Cited by 41
Downstream Processing: From Egg to Cell Culture‐Derived Influenza Virus Particles
Wolff, M. W., & Reichl, U. (2008) · Chemical Engineering & Technology · doi:10.1002/ceat.200800118 · Cited by 41
In vitro synthesis of heparosan using recombinant Pasteurella multocida heparosan synthase PmHS2
Chavaroche, A. A. E., Springer, J., Kooy, F. K., Boeriu, C. G., & Eggink, G. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2214-2 · Cited by 41
A Dilemma in the Glycosaminoglycan‐Based Therapy: Synthetic or Naturally Unique Molecules?
Pomin, V. H. (2015) · Medicinal Research Reviews · doi:10.1002/med.21356 · Cited by 44
“Structurea β-D-GlcA-(1-3)-β-D-GlcNAc-(1-4)-β-D-GlcA-(1-3)-β-D-GlcNAc-(1)-OMP β-D-GlcNAc-(1-4)-β-D-GlcA-(1-3)-β-D-GlcNAc-(1-4)-β-D-GlcNAc-(1)-OMP β-D-GlcA-(1-3)-β-D-GlcNAc-(1)-OMP β-D-GlcA-(1-3)-β-D-GlcNAc-(1-4)-β-D-GlcA-(1)-OMP β-D-GlcNAc-(1-4)-β-D-GlcA-(1)-OMP β-D-GlcNAc-(1-4)-β-D-GlcA-(1-3)-β-D-GlcNAc-(1-4)-β-D-GlcN…”
BackgroundLi, G., Yang, B., Li, L., Zhang, F., Xue, C., & Linhardt, R. J. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.02.033 · Cited by 40
“Heparin is also microheterogenous with some of the uronic acid residues substituted with 2-O-sulfo groups and some of the GlcN residues substituted with 6-O-sulfo and or 3-O-sulfo groups and with N-sulfo groups, Nacetyl groups or N-unsubstituted [3,4].”
Mohamed, S., He, Q., Singh, A. A., & Ferro, V. (2020) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/bs.accb.2019.09.001 · Cited by 42
Lembo, D., Donalisio, M., Laine, C., Cagno, V., Civra, A., Bianchini, E. P., Zeghbib, N., & Bouchemal, K. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.05.007 · Cited by 40
“HS are structurally related to heparin except that heparin has higher level of sulfation and higher content of iduronic acid [3,4].”
BackgroundSommers, C. D., Mans, D. J., Mecker, L. C., & Keire, D. A. (2011) · Analytical Chemistry · doi:10.1021/ac200011s · Cited by 40
Kalathottukaren, M. T., Abbina, S., Yu, K., Shenoi, R. A., Creagh, A. L., Haynes, C., & Kizhakkedathu, J. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00994 · Cited by 30
Hu, Y. J., Wu, X., & Jinrui, X. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.11.104 · Cited by 40
Li, Y., Han, M., Wang, Y., Liu, Q., Zhao, W., Su, B., & Zhao, C. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.08.118 · Cited by 39
Polysaccharide and protein-based functional wound dressing materials and applications
Debele, T. A., & Su, W. (2020) · International Journal of Polymeric Materials · doi:10.1080/00914037.2020.1809403 · Cited by 42
From Cancer to COVID‐19: A Perspective on Targeting Heparan Sulfate‐Protein Interactions
Chhabra, M., Doherty, G. G., See, N. W., Gandhi, N. S., & Ferro, V. (2021) · The Chemical Record · doi:10.1002/tcr.202100125 · Cited by 39
Guan, Y., Xu, X., Liu, X.-Y., Sheng, A.-R., Jin, L., Linhardt, R., & Chi, L.-L. (2016) · Journal of Pharmacy and Science · doi:10.1016/j.xphs.2016.03.037 · Cited by 38
Bromfield, S. M., & Smith, D. K. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b04344 · Cited by 31
Low-molecular-weight sulfonated chitosan as template for anticoagulant nanoparticles
Heise, K., Hobisch, M. A., Săcărescu, L., Maver, U., Hobisch, J., Reichelt, T., Sega, M., Fischer, S., & Spirk, S. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s172230 · Cited by 38
“There are two options of how our samples interact with factor Xa.”
InfluentialA cyanine based dicationic molecular rotor probe for dual sensing of heparin
Pandey, S. P., Jha, P., & Singh, P. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.115327 · Cited by 39
Investigating the effect of VEGF glycosylation on glycosaminoglycan binding and protein unfolding
Brandner, B., Kurkela, R., Vihko, P., & Kungl, A. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.079 · Cited by 38
Sommers, C. D., Ye, H., Kolinski, R. E., Nasr, M. M., Buhse, L. F., Al-Hakim, A. H., & Keire, D. A. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5362-z · Cited by 38
“Heparin is a heterogeneous polysaccharide of varying chain length that primarily consists of a repeating iduronic acid with a 2-O-sulfate group and glucosamine with N-sulfate and 6-O-sulfate groups [1, 2].”
BackgroundDe Novo Sequencing of Complex Mixtures of Heparan Sulfate Oligosaccharides
Huang, R., Zong, C., Venot, A. P., Chiu, Y., Zhou, D., Boons, G., & Sharp, J. S. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b00519 · Cited by 38
Kanabar, V., Hirst, S. J., O'Connor, B. J., & Page, C. P. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706333 · Cited by 38
“This is similar to reports elsewhere for inhibition of cell adhesion (San Antonio et al., 1992) and loosely correlates with the empirical sulphate content for each of the GAGs examined where heparin4HS4CSB¼ CSA4HA (Rabenstein, 2002).”
BackgroundResultInfluentialGelmi, A. A., Higgins, M. J., & Wallace, G. G. (2012) · Small · doi:10.1002/smll.201201686 · Cited by 39
Fernández, C., Hattan, C., & Kerns, R. (2006) · Carbohydrate Research · doi:10.1016/j.carres.2006.04.014 · Cited by 37
Langeslay, D. J., Beecher, C. N., Naggi, A., Guerrini, M., Torri, G., & Larive, C. K. (2012) · Analytical Chemistry · doi:10.1021/ac3032788 · Cited by 35
Agyekum, I., Zong, C., Boons, G., & Amster, I. J. (2017) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-017-1643-x · Cited by 38
“Sulfo modifications may occur at the 2-O position of the uronic acid, and the N-, 3-O, and 6-O positions of the glucosamine unit [8].”
Mubaiwa, T. D., Semchenko, E. A., Hartley‐Tassell, L. E., Day, C. J., Jennings, M. P., & Seib, K. L. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx063 · Cited by 37
“Heparin and heparan sulfate are both highly sulphated glycans, with heparin being found primarily in mast cell granules while heparan sulfate is found in plasma, the extracellular matrix and on cell surfaces of most mammalian cells (Rabenstein 2002).”
BackgroundLi, J., Xu, J., Guo, W., Zhong, W., Li, Q., Tan, L., & Shang, L. (2019) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2019.127422 · Cited by 37
Driguez, P., Potier, P., & Trouilleux, P. (2014) · Natural Product Reports · doi:10.1039/c4np00012a · Cited by 37
Heparin: new life for an old drug.
Aláez-Versón, C. R., Lantero, E., & Fernández-Busquets, X. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0127 · Cited by 33
Yu, F., Wolff, J. J., Amster, I. J., & Prestegard, J. H. (2007) · Journal of the American Chemical Society · doi:10.1021/ja075272h · Cited by 37
Huang, L.-S., & Kerns, R. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.11.013 · Cited by 32
Al‐Horani, R. A., Liang, A., & Desai, U. R. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2008387 · Cited by 38
Jones, C. J., Membreno, N., & Larive, C. K. (2009) · Journal of Chromatography A · doi:10.1016/j.chroma.2009.11.064 · Cited by 41
Plant cell adhesion: A bioassay facilitates discovery of the first pectin biosynthetic gene
Lord, E. M., & Mollet, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012685099 · Cited by 36
Tatai, J., & Fügedi, P. (2008) · Tetrahedron · doi:10.1016/j.tet.2008.08.021 · Cited by 31
Redox-Responsive Heparin–Chlorambucil Conjugate Polymeric Prodrug for Improved Anti-Tumor Activity
Andrgie, A. T., Birhan, Y. S., Mekonnen, T. W., Hanurry, E. Y., Darge, H. F., Lee, R., Chou, H., & Tsai, H. (2019) · Polymers · doi:10.3390/polym12010043 · Cited by 35
“Heparin is a highly anioic natural polysaccharide commonly used as an anticoagulant in clinical practice [9,10].”
BackgroundChavante, S. F., Brito, A. S., de Lima, M. A., Yates, E. A., Nader, H. B., Guerrini, M., Torri, G., & Bisio, A. (2014) · Carbohydrate Research · doi:10.1016/j.carres.2014.03.002 · Cited by 35
Wakao, M., Saito, A., Ohishi, K., Kishimoto, Y., Nishimura, T., Sobel, M., & Suda, Y. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.069 · Cited by 30
Characterization of currently marketed heparin products: Key tests for LMWH quality assurance
Ye, H., Toby, T. K., Sommers, C. D., Ghasriani, H., Trehy, M. L., Ye, W., Kolinski, R. E., Buhse, L. F., Al-Hakim, A. H., & Keire, D. A. (2013) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.06.033 · Cited by 35
“/ Journal of Pharmaceutical and Biomedical Analysis 85 (2013) 99– 107 103”
BackgroundInfluentialRoberts, J. J., Naudiyal, P., Jugé, L., Bilston, L. E., Granville, A. M., & Martens, P. J. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00321 · Cited by 34
Metadata
- Authors
- Rabenstein, D. L.
- Affiliations
- University of California, Riverside (US)
- Corresponding author
- Rabenstein, Dallas L.
- Venue
- Natural Product Reports
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2002-03-06
- Volume
- 19
- Issue
- 3
- Pages
- 312-331
- ISSN
- 0265-0568 (ISSN-L)
- 1460-4752
- OpenAlex
- W2121886286
- Cited by
- 870
- References
- 158
- Citations by year
- 2026: 14 · 2025: 32 · 2024: 36 · 2023: 36 · 2022: 41 · 2021: 48 · 2020: 50 · 2019: 44 · 2018: 39 · 2017: 47 · 2016: 48 · 2015: 50 · 2014: 47 · 2013: 45 · 2012: 37
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Natural Product Reports (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL56588, R01HL056588)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Polysaccharides and Plant Cell Walls
- Life Sciences › Agricultural and Biological Sciences › Food Science › Polysaccharides Composition and Applications
- Keywords
- heparin, heparan sulfate, glycosaminoglycans, oligosaccharide structure, oligosaccharide sequencing, heparin biosynthesis, heparan sulfate biosynthesis, biological activity
- MeSH terms
- Binding Sites, Blood Coagulation, Carbohydrate Conformation, Carbohydrate Sequence, Disaccharides, Glycosaminoglycans, Growth Substances, Heparin, Heparan Sulfate, Lipase, Lipoproteins, Mast Cells, Molecular Sequence Data, Magnetic Resonance Spectroscopy, HIV-1, Herpesvirus 1, Human, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.